Lansen is a specialty pharmaceutical group principally engaged in the development,production and sale of specialty prescription western pharmaceuticals for the treatment of rheumatic diseases in the PRC.
Its core business currently comprised five rheumatic specialty prescription western pharmaceuticals. During the past three years, the group recorded strong and rapid growth. It is also engaged in the production and sale of other pharmaceuticals in the PRC.
To find out more about Lansen visit www.lansen.com.
